Literature DB >> 22274402

Molecular and genetic profiles of radiographically defined de novo meningiomas.

Yohei Kitamura1, Hikaru Sasaki, Kazunari Yoshida.   

Abstract

With the exception of radiation-induced tumors, benign meningiomas that are known to have developed within a defined time period are extremely rare. We have genetically characterized two cases of radiographically defined de novo, sporadic meningiomas--a 5-cm, left parasagittal tumor in a 61-year-old male and a 2.3-cm, right falx tumor in a 53-year-old female. Neither tumor was observed during MRIs performed for unrelated complaints 49 and 28 months before surgery, respectively. Both tumors were totally resected, and histopathological examination revealed WHO grade I meningiomas. In both cases, the MIB-1 staining indices were high for grade I meningioma (5.6% for case 1 and 9.1% for case 2), and abnormal accumulation of p53 were observed by immunohistochemistry. The two tumors shared losses of chromosome arms 1p and 7p by comparative genomic hybridization. The tumor suppressor merlin, product of the NF2 gene, was not detected in either tumor. These abnormalities found in common in both of the de novo meningiomas likely to play significant roles in the pathogenesis and/or rapid development of meningiomas. Moreover, taken together with previous studies, our findings indicate that the combined loss of 1p and 7p may play a critical role in the tumorigenesis of de novo, aggressive meningiomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274402     DOI: 10.1007/s11060-012-0797-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.

Authors:  S Ozaki; T Nishizaki; H Ito; K Sasaki
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.

Authors:  Shigeo Ohba; Masahito Kobayashi; Takashi Horiguchi; Satoshi Onozuka; Kazunari Yoshida; Takayuki Ohira; Takeshi Kawase
Journal:  J Neurosurg       Date:  2010-12-17       Impact factor: 5.115

3.  Reduced expression of schwannomin/merlin in human sporadic meningiomas.

Authors:  J H Lee; V Sundaram; D J Stein; S E Kinney; D W Stacey; M Golubić
Journal:  Neurosurgery       Date:  1997-03       Impact factor: 4.654

4.  Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.

Authors:  D X Cai; R Banerjee; B W Scheithauer; C M Lohse; B K Kleinschmidt-Demasters; A Perry
Journal:  J Neuropathol Exp Neurol       Date:  2001-06       Impact factor: 3.685

5.  Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.

Authors:  V J Amatya; Y Takeshima; K Sugiyama; K Kurisu; T Nishisaka; T Fukuhara; K Inai
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

6.  Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study.

Authors:  T Hitotsumatsu; T Iwaki; T Kitamoto; M Mizoguchi; S O Suzuki; Y Hamada; M Fukui; J Tateishi
Journal:  Acta Neuropathol       Date:  1997-03       Impact factor: 17.088

7.  Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

Authors:  K Ueki; C Wen-Bin; Y Narita; A Asai; T Kirino
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

8.  Monosomy 7p in meningiomas: a rare constituent of tumor progression.

Authors:  Wolfram Henn; Isolde Niedermayer; Ralf Ketter; Sylvia Reichardt; Arno Freiler; Klaus D Zang
Journal:  Cancer Genet Cytogenet       Date:  2003-07-01

9.  Allelic loss at 1p is associated with tumor progression of meningiomas.

Authors:  M J Bello; J M de Campos; M E Kusak; J Vaquero; J L Sarasa; A Pestaña; J A Rey
Journal:  Genes Chromosomes Cancer       Date:  1994-04       Impact factor: 5.006

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.